There is also another oral version of semaglutide called Rybelsus, which also has the same patent timeline
Similarly, liraglutide has demonstrated neuroprotective effects against cuprizone-induced demyelination within an experimental model of MS established in mice through anti-inflammatory mechanisms, autophagy activation, NLRP3 inflammasome suppression, and anti-apoptotic processes
Gastrointestinal side effectsnausea, vomiting, constipationsometimes force dose reductions that fall below therapeutic thresholds, stalling weight loss momentum
GLP-3 Cagrilintide Research Peptide Representative Literature (Independent Amylin-Analog / Dual-Incretin / Triple-Agonist Signaling Research | Research Use Only) The publications listed below provide general scientific context on amylin-receptor biology, incretin-pathway modulation, and multi-agonist peptide frameworks